发明申请
US20070037822A1 Azinone and diazinone V3 inhibitors for depression and stress disorders
失效
氮嗪酮和二嗪酮V3抑制剂用于抑郁和应激障碍
- 专利标题： Azinone and diazinone V3 inhibitors for depression and stress disorders
- 专利标题（中）： 氮嗪酮和二嗪酮V3抑制剂用于抑郁和应激障碍
-
申请号： US11422710申请日： 2006-06-07
-
公开(公告)号： US20070037822A1公开(公告)日： 2007-02-15
- 发明人: Jeffrey Letourneau , Koc-Kan Ho , Michael Ohlmeyer , Patrick Jokiel , Christopher Riviello
- 申请人： Jeffrey Letourneau , Koc-Kan Ho , Michael Ohlmeyer , Patrick Jokiel , Christopher Riviello
- 申请人地址： US NJ Princeton
- 专利权人： Pharmacopeia Drug Discovery, Inc.
- 当前专利权人： Pharmacopeia Drug Discovery, Inc.
- 当前专利权人地址： US NJ Princeton
- 主分类号： A61K31/513
- IPC分类号： A61K31/513 ; A61K31/4965 ; A61K31/4412 ; C07D213/63 ; C07D239/02
摘要：
Substituted pyridines, pyrimidines, pyrazines, pyridinones, pyrimidinones, pyrazinones and phenylacetamides useful in treating depression, stress and other disorders are disclosed. The compounds are of the formualae: Other embodiments are also disclosed.